Perfosfamide
Perfosfamide is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| cyhot cream with lidocaine | OTC monograph not final | 2018-02-20 |
| dch nerve pain relief roll-on | C200263 | 2024-12-19 |
| dch pain relief | C200263 | 2024-12-19 |
| dch pain relief roll-on | C200263 | 2024-12-19 |
| dermfree hemorrhoid | C200263 | 2024-08-15 |
| equate pain relief cream | C200263 | 2023-12-19 |
| fluconazole 4% / ibuprofen 2% / itraconazole 1% / terbinafine hcl 4% | unapproved drug other | 2019-04-24 |
| healmusz hemorrhoid fissure | C200263 | 2024-01-17 |
| lidocaine hcl 4 percent | C200263 | 2024-04-30 |
| lidocaine hcl 4% | OTC monograph not final | 2022-04-12 |
Show 16 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
No data
Drug
General
| Drug common name | Perfosfamide |
| INN | perfosfamide |
| Description | 4-hydroperoxycyclophosphamide is a phosphorodiamide that is the active metabolite of the nitrogen mustard cyclophosphamide. It has potent antineoplastic and immunosuppressive properties. It has a role as an antineoplastic agent, an immunosuppressive agent, an alkylating agent, a metabolite and a drug allergen. It is a phosphorodiamide, a nitrogen mustard, a peroxol and an organochlorine compound. |
| Classification | Small molecule |
| Drug class | phosphoro-derivatives; isophosphoramide mustard derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=P1(N(CCCl)CCCl)NC(OO)CCO1 |
Identifiers
| PDB | — |
| CAS-ID | 39800-16-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL61511 |
| ChEBI ID | 196991 |
| PubChem CID | 38347 |
| DrugBank | — |
| UNII ID | U880A4FUDA (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use